| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $377.2M | +5.4% |
| Cost of Revenue | $223.7M | +23.2% |
| Gross Profit | $153.5M | -13.0% |
| R&D Expense | $21.9M | +32.4% |
| SG&A Expense | $43.9M | +16.0% |
| Operating Income | -$85.2M | -1022.5% |
| Pre-tax Income | -$83.3M | -1061.6% |
| Income Tax | $504K | -96.6% |
| Net Income | -$83.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $187.0M | -20.6% |
| Accounts Receivable | $62.7M | +156.5% |
| Inventory | $34.1M | +7.0% |
| Current Assets | $304.6M | -7.5% |
| Total Assets | $405.0M | -17.3% |
| Current Liabilities | $65.3M | +6.2% |
| Total Liabilities | $107.6M | -9.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.5M | -258.8% |
| Capital Expenditures | $3.3M | -39.1% |
| Investing Cash Flow | -$10.9M | +25.7% |
| Financing Cash Flow | $380K | -97.5% |
| Free Cash Flow | -$40.9M | -325.2% |
| -1222.8% |
| EPS (Basic) | -$3.67 | -1210.7% |
| EPS (Diluted) | -$3.67 | -1210.7% |
| Stockholders' Equity |
| $297.4M |
| -19.7% |